Covenant Asset Management, LLC Bristol Myers Squibb CO Transaction History

Covenant Asset Management, LLC

$631 Million
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$47.98 - $54.4 $623,020 - $706,384	-12,985 Reduced 77.1%	3,857 $209,000
Q4 2023 Jan 22, 2024	SELL	$48.48 - $57.85 $370,435 - $442,031	-7,641 Reduced 31.21%	16,842 $864,000
Q3 2023 Oct 31, 2023	BUY	$57.89 - $64.73 $6,541 - $7,314	113 Added 0.46%	24,483 $1.42 Million
Q2 2023 Jul 12, 2023	SELL	$63.71 - $70.74 $14,016 - $15,562	-220 Reduced 0.89%	24,370 $1.56 Million
Q1 2023 Apr 27, 2023	SELL	$65.71 - $74.53 $341,166 - $386,959	-5,192 Reduced 17.43%	24,590 $1.7 Million
Q4 2022 Jan 24, 2023	BUY	$68.48 - $81.09 $282,274 - $334,252	4,122 Added 16.06%	29,782 $0
Q3 2022 Nov 03, 2022	BUY	$0.13 - $76.84 $72 - $42,646	555 Added 2.21%	25,660 $1.82 Million
Q2 2022 Jul 21, 2022	BUY	$72.62 - $79.98 $3,413 - $3,759	47 Added 0.19%	25,105 $1.93 Million
Q1 2022 Apr 29, 2022	BUY	$61.48 - $73.72 $1,168 - $1,400	19 Added 0.08%	25,058 $1.83 Million
Q4 2021 Jan 26, 2022	SELL	$53.63 - $62.52 $18,234 - $21,256	-340 Reduced 1.34%	25,039 $1.56 Million
Q3 2021 Oct 15, 2021	BUY	$59.17 - $69.31 $3,550 - $4,158	60 Added 0.24%	25,379 $1.5 Million
Q2 2021 Jul 21, 2021	BUY	$61.91 - $67.42 $38,693 - $42,137	625 Added 2.53%	25,319 $1.69 Million
Q1 2021 Apr 19, 2021	BUY	$59.34 - $66.74 $13,885 - $15,617	234 Added 0.96%	24,694 $1.56 Million
Q4 2020 Jan 28, 2021	SELL	$57.74 - $65.43 $12,298 - $13,936	-213 Reduced 0.86%	24,460 $1.52 Million
Q3 2020 Oct 29, 2020	BUY	$57.43 - $63.64 $1,263 - $1,400	22 Added 0.09%	24,673 $1.49 Million
Q2 2020 Jul 24, 2020	BUY	$54.82 - $64.09 $53,285 - $62,295	972 Added 4.1%	24,651 $1.45 Million
Q1 2020 Apr 22, 2020	BUY	$46.4 - $67.43 $69,414 - $100,875	1,496 Added 6.74%	23,679 $1.32 Million
Q4 2019 Jan 24, 2020	BUY	$49.21 - $64.19 $393 - $513	8 Added 0.04%	22,183 $1.42 Million
Q3 2019 Oct 18, 2019	BUY	$42.77 - $50.71 $126,984 - $150,557	2,969 Added 15.46%	22,175 $1.12 Million
Q2 2019 Jul 17, 2019	BUY	$44.62 - $49.34 $35,696 - $39,472	800 Added 4.35%	19,206 $871,000
Q1 2019 Apr 26, 2019	BUY	$45.12 - $53.8 $82,569 - $98,454	1,830 Added 11.04%	18,406 $878,000
Q3 2018 Oct 09, 2018	BUY	$55.19 - $62.25 $22,076 - $24,900	400 Added 2.47%	16,576 $1.03 Million
Q2 2018 Jul 12, 2018	BUY	$50.53 - $62.98 $55,987 - $69,781	1,108 Added 7.35%	16,176 $895,000
Q1 2018 May 04, 2018	BUY	$59.92 - $68.98 $86,224 - $99,262	1,439 Added 10.56%	15,068 $953,000
Q4 2017 Jan 12, 2018	BUY	$59.94 - $65.35 $94,645 - $103,187	1,579 Added 13.1%	13,629 $835,000
Q3 2017 Oct 19, 2017	BUY	$55.23 - $63.74 $665,521 - $768,067	12,050	12,050 $768,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.24 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.41 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.54 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.55 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covenant Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Covenant Asset Management, LLC with notifications on news.

Account